The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Malaria medicines: a glass half full?
Abstract
Despite substantial scientific progress over the past two decades, malaria remains a worldwide burden that causes hundreds of thousands of deaths every year. New, affordable and safe drugs are required to overcome increasing resistance against artemisinin-based treatments, treat vulnerable populations, interrupt the parasite life cycle by blocking transmission to the vectors, prevent infection and target malaria species that transiently remain dormant in the liver. In this Review, we discuss how the antimalarial drug discovery pipeline has changed over the past 10 years, grouped by the various target compound or product profiles, to assess progress and gaps, and to recommend priorities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
The economic and social burden of malaria
Sachs, J., & Malaney, P. (2002) · Nature · doi:10.1038/415680a · Cited by 2,248
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
Insecticide-treated bed nets and curtains for preventing malaria
Lengeler, C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000363.pub2 · Cited by 1,700
Doolan, D. L., Dobaño, C., & Baird, J. K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00025-08 · Cited by 1,301
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Türbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H. K., et al. (1999) · Science · doi:10.1126/science.285.5433.1573 · Cited by 1,173
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Dondorp, A. M., Fanello, C. I., Hendriksen, I. C., Gomes, E., Seni, A., Chhaganlal, K. D., Bojang, K., Olaosebikan, R., Anunobi, N., Maitland, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61924-1 · Cited by 1,022
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
Thousands of chemical starting points for antimalarial lead identification
Gamo, F.-J., Sanz, L. M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J.-L., Vanderwall, D. E., Green, D. V. S., Kumar, V., Hasan, S., et al. (2010) · Nature · doi:10.1038/nature09107 · Cited by 996
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924
Campbell, M. C., & Tishkoff, S. A. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164258 · Cited by 861
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
Seder, R. A., Chang, L.-J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J., Holman, L. A., James, E. R., Billingsley, P. F., Gunasekera, A., et al. (2013) · Science · doi:10.1126/science.1241800 · Cited by 761
Norwalk Virus Shedding after Experimental Human Infection
Atmar, R. L., Opekun, A. R., Gilger, M. A., Estes, M. K., Crawford, S. E., Neill, F. H., & Graham, D. Y. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1410.080117 · Cited by 760
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Straimer, J., Gnädig, N. F., Witkowski, B., Amaratunga, C., Duru, V., Ramadani, A. P., Dacheux, M., Khim, N., Zhang, L., Lam, S., et al. (2015) · Science · doi:10.1126/science.1260867 · Cited by 728
A Research Agenda to Underpin Malaria Eradication
Alonso, P. L., Brown, G., Arevalo-Herrera, M., Binka, F., Chitnis, C., Collins, F., Doumbo, O. K., Greenwood, B., Hall, B. F., Levine, M. M., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000406 · Cited by 667
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
Genetic architecture of artemisinin-resistant Plasmodium falciparum
Miotto, O., Amato, R., Ashley, E. A., MacInnis, B., Almagro-Garcia, J., Amaratunga, C., Lim, P., Mead, D., Oyola, S. O., Dhorda, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3189 · Cited by 609
Chemical genetics of Plasmodium falciparum
Guiguemde, W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., et al. (2010) · Nature · doi:10.1038/nature09099 · Cited by 566
Self-citationLive Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8 + T Cell Immunity
Epstein, J. E., Tewari, K., Lyke, K. E., Sim, B. K. L., Billingsley, P. F., Laurens, M. B., Gunasekera, A., Chakravarty, S., James, E. R., Sedegah, M., et al. (2011) · Science · doi:10.1126/science.1211548 · Cited by 533
Continuous‐Flow Synthesis of the Anti‐Malaria Drug Artemisinin
Lévesque, F., & Seeberger, P. H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107446 · Cited by 516
Malaria resurgence: a systematic review and assessment of its causes
Cohen, J. M., Smith, D. L., Cotter, C., Ward, A., Yamey, G., Sabot, O. J., & Moonen, B. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-122 · Cited by 514
The RTS, S. C. T. P. (. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001685 · Cited by 474
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
Yeung, B. K. S., Zou, B., Rottmann, M., Lakshminarayana, S. B., Ang, S. H., Leong, S. Y., Tan, J., Wong, J., Keller-Maerki, S., Fischli, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100410f · Cited by 432
Targeting Plasmodium PI(4)K to eliminate malaria
McNamara, C. W., Lee, M. C. S., Lim, C. S., Lim, S. H., Roland, J., Nagle, A., Simon, O., Yeung, B. K. S., Chatterjee, A. K., McCormack, S. L., et al. (2013) · Nature · doi:10.1038/nature12782 · Cited by 431
The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
Spangenberg, T., Burrows, J. N., Kowalczyk, P., McDonald, S., Wells, T. N. C., & Willis, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062906 · Cited by 341
Self-citationImaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
Antimalarial drug discovery — approaches and progress towards new medicines
Flannery, E. L., Chatterjee, A. K., & Winzeler, E. A. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3138 · Cited by 313
Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia
Witkowski, B., Khim, N., Chim, P., Kim, S., Ke, S., Kloeung, N., Chy, S., Duong, S., Leang, R., Ringwald, P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01868-12 · Cited by 308
New medicines to improve control and contribute to the eradication of malaria
Wells, T. N. C., Alonso, P. L., & Gutteridge, W. E. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2972 · Cited by 298
Self-citationA Research Agenda for Malaria Eradication: Drugs
The malERA Consultative Group on Drugs (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000402 · Cited by 288
Coteron, J. M., Marco, M., Esquivias, J., Deng, X., White, K. L., White, J., Koltun, M., El Mazouni, F., Kokkonda, S., Katneni, K., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200592f · Cited by 287
Designing the next generation of medicines for malaria control and eradication
Burrows, J. N., Hooft van Huijsduijnen, R., Möhrle, J. J., Oeuvray, C., & Wells, T. N. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-187 · Cited by 282
Self-citationYuthavong, Y., Tarnchompoo, B., Vilaivan, T., Chitnumsub, P., Kamchonwongpaisan, S., Charman, S. A., McLennan, D. N., White, K. L., Vivas, L., Bongard, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204556109 · Cited by 277
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Rappuoli, R., & Aderem, A. (2011) · Nature · doi:10.1038/nature10124 · Cited by 273
Neglect of Plasmodium vivax malaria
Baird, J. K. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.011 · Cited by 266
Drug‐ and non‐drug‐associated QT interval prolongation
Van Noord, C., Eijgelsheim, M., & Stricker, B. H. C. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03660.x · Cited by 264
Kyes, S., Christodoulou, Z., Pinches, R., Kriek, N., Horrocks, P., & Newbold, C. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05587.x · Cited by 257
Spillman, N. J., Allen, R. J. W., McNamara, C. W., Yeung, B. K. S., Winzeler, E. A., Diagana, T. T., & Kirk, K. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2012.12.006 · Cited by 246
Jiménez-Díaz, M. B., Ebert, D., Salinas, Y., Pradhan, A., Lehane, A. M., Myrand-Lapierre, M.-E., O’Loughlin, K. G., Shackleford, D. M., Justino de Almeida, M., Carrillo, A. K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414221111 · Cited by 245
Llanos-Cuentas, A., Lacerda, M. V., Rueangweerayut, R., Krudsood, S., Gupta, S. K., Kochar, S. K., Arthur, P., Chuenchom, N., Möhrle, J. J., Duparc, S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62568-4 · Cited by 242
Spiroindolone KAE609 for Falciparum and Vivax Malaria
White, N. J., Pukrittayakamee, S., Phyo, A. P., Rueangweerayut, R., Nosten, F., Jittamala, P., Jeeyapant, A., Jain, J. P., Lefèvre, G., Li, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315860 · Cited by 240
Increased Pyrethroid Resistance in Malaria Vectors and Decreased Bed Net Effectiveness, Burkina Faso
Toé, K. H., Jones, C. M., N’Fale, S., Ismail, H. M., Dabiré, R. K., & Ranson, H. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2010.140619 · Cited by 233
Recent advances in malaria drug discovery
Biamonte, M. A., Wanner, J., & Le Roch, K. G. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.067 · Cited by 226
Alving, C. R., Peachman, K. K., Rao, M., & Reed, S. G. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.03.008 · Cited by 225
Combinatorial compound libraries for drug discovery: an ongoing challenge
Mario Geysen, H., Schoenen, F., Wagner, D., & Wagner, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1035 · Cited by 224
A Continuous‐Flow Process for the Synthesis of Artemisinin
Kopetzki, D., Lévesque, F., & Seeberger, P. H. (2013) · Chemistry – A European Journal · doi:10.1002/chem.201204558 · Cited by 218
March, S., Ng, S., Velmurugan, S., Galstian, A., Shan, J., Logan, D. J., Carpenter, A. E., Thomas, D., Sim, B. K. L., Mota, M. M., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.005 · Cited by 212
Bousema, T., Dinglasan, R. R., Morlais, I., Gouagna, L. C., van Warmerdam, T., Awono-Ambene, P. H., Bonnet, S., Diallo, M., Coulibaly, M., Tchuinkam, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042821 · Cited by 210
Global health improvement and WHO: shaping the future
Jong-wook, L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15107-0 · Cited by 189
The antimalarial ferroquine: from bench to clinic
Biot, C., Nosten, F., Fraisse, L., Ter-Minassian, D., Khalife, J., & Dive, D. (2011) · Parasite · doi:10.1051/parasite/2011183207 · Cited by 180
Bosman, A., & Mendis, K. N. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.193 · Cited by 180
Natural products as starting points for future anti-malarial therapies: going back to our roots?
Wells, T. N. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-s1-s3 · Cited by 176
Self-citationPeters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00003 · Cited by 174
Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures
Dembélé, L., Franetich, J.-F., Lorthiois, A., Gego, A., Zeeman, A.-M., Kocken, C. H. M., Le Grand, R., Dereuddre-Bosquet, N., van Gemert, G.-J., Sauerwein, R., et al. (2014) · Nature Medicine · doi:10.1038/nm.3461 · Cited by 172
Kyes, S. A., Kraemer, S. M., & Smith, J. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00173-07 · Cited by 170
McCarthy, J. S., Sekuloski, S., Griffin, P. M., Elliott, S., Douglas, N., Peatey, C., Rockett, R., O'Rourke, P., Marquart, L., Hermsen, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021914 · Cited by 169
Gesase, S., Gosling, R. D., Hashim, R., Ord, R., Naidoo, I., Madebe, R., Mosha, J. F., Joho, A., Mandia, V., Mrema, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004569 · Cited by 169
The global pipeline of new medicines for the control and elimination of malaria
Anthony, M. P., Burrows, J. N., Duparc, S., JMoehrle, J., & Wells, T. N. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-316 · Cited by 167
Self-citationModels for open innovation in the pharmaceutical industry
Schuhmacher, A., Germann, P., Trill, H., & Gassmann, O. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.013 · Cited by 165
Identification of inhibitors of Plasmodium falciparum gametocyte development
Duffy, S., & Avery, V. M. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-408 · Cited by 158
Kuhen, K. L., Chatterjee, A. K., Rottmann, M., Gagaring, K., Borboa, R., Buenviaje, J., Chen, Z., Francek, C., Wu, T., Nagle, A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02727-13 · Cited by 158
Harrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., & Duffy, P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir376 · Cited by 156
A Concise Synthesis of (+)-Artemisinin
Zhu, C., & Cook, S. P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3061479 · Cited by 153
Intermittent preventive treatment for malaria in children living in areas with seasonal transmission
Meremikwu, M. M., Donegan, S., Sinclair, D., Esu, E., & Oringanje, C. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003756.pub4 · Cited by 145
Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii
Murphy, R. C., Ojo, K. K., Larson, E. T., Castellanos-González, A., Perera, B. G. K., Keyloun, K. R., Kim, J. E., Bhandari, J. G., Mueller, N. R., Verlinde, C. L. M. J., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100096t · Cited by 144
Mzayek, F., Deng, H., Mather, F. J., Wasilevich, E. C., Liu, H., Hadi, C. M., Chansolme, D. H., Murphy, H. A., Melek, B. H., Tenaglia, A. N., et al. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020006 · Cited by 137
Vaidya, A. B., Morrisey, J. M., Zhang, Z., Das, S., Daly, T. M., Otto, T. D., Spillman, N. J., Wyvratt, M. J., Siegl, P. K. S., Marfurt, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6521 · Cited by 136
O’Neill, P. M., Amewu, R. K., Nixon, G. L., Garah, F. E., Mungthin, M., Chadwick, J., Shone, A. E., Vivas, L., Lander, H., Barton, V., et al. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201001026 · Cited by 135
Origin and Evolution of Sulfadoxine Resistant Plasmodium falciparum
Vinayak, S., Alam, T., Mixson-Hayden, T. R., McCollum, A. M., Sem, R., Shah, N. K., Lim, P., Muth, S., Rogers, W. O., Fandeur, T., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000830 · Cited by 132
Deng, X., Gujjar, R., Mazouni, F. E., Kaminsky, W., Malmquist, N. A., Goldsmith, E. J., Rathod, P. K., & Phillips, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028589 · Cited by 128
Investigation of the Redox Behavior of Ferroquine, a New Antimalarial
Leleu‐Chavain, N., Vezin, H., Dive, D., Touati, N., Paul, J., Buisine, E., & Biot, C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800007x · Cited by 124
The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya
Sicuri, E., Vieta, A., Lindner, L., Constenla, D. O., & Sauboin, C. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-307 · Cited by 119
Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug
da Cruz, F. P., Martin, C., Buchholz, K., Lafuente-Monasterio, M. J., Rodrigues, T., Sönnichsen, B., Moreira, R., Gamo, F., Marti, M., Mota, M. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis184 · Cited by 114
Deng, X., Kokkonda, S., Mazouni, F. E., White, J. C., Burrows, J. N., Kaminsky, W., Charman, S. A., Matthews, D. J., Rathod, P. K., & Phillips, M. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500481t · Cited by 113
Krishna, S., Woodrow, C. J., Webb, R. J., Penny, J., Takeyasu, K., Kimura, M., & East, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010554200 · Cited by 108
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria
Zani, B., Gathu, M., Donegan, S., Olliaro, P., & Sinclair, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010927 · Cited by 106
Leong, F. J., Li, R., Jain, J. P., Lefèvre, G. Y., Magnusson, B., Diagana, T. T., & Pertel, P. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03393-14 · Cited by 105
Malaria Control and Elimination,1 Venezuela, 1800s–1970s
Griffing, S. M., Villegas, L., & Udhayakumar, V. (2014) · Emerging infectious diseases · doi:10.3201/eid2010.130917 · Cited by 102
Antimalarial 4(1H)-pyridones bind to the Q i site of cytochrome bc 1
Capper, M. J., O’Neill, P. M., Fisher, N. E., Strange, R. W., Moss, D. M., Ward, S. A., Berry, N. G., Lawrenson, A. S., Hasnain, S. S., Biagini, G. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416611112 · Cited by 101
A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b Inhibitor
Nam, T., McNamara, C. W., Bopp, S. E. R., Dharia, N. V., Meister, S., Bonamy, G. M. C., Plouffe, D., Kato, N., McCormack, S., Bursulaya, B. D., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb200105d · Cited by 98
Diverse chemotypes disrupt ion homeostasis in the malaria parasite
Lehane, A. M., Ridgway, M. C., Baker, E., & Kirk, K. (2014) · Molecular Microbiology · doi:10.1111/mmi.12765 · Cited by 93
Supan, C., Mombo‐Ngoma, G., Dal-Bianco, M. P., Salazar, C. L. O., Issifou, S., Mazuir, F., Filali‐Ansary, A., Biot, C., Ter-Minassian, D., Ramharter, M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05359-11 · Cited by 90
Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939
Sumanadasa, S. D. M., Goodman, C. D., Lucke, A. J., Skinner‐Adams, T. S., Sahama, I., Haque, A., Do, T. A., McFadden, G. I., Fairlie, D. P., & Andrews, K. T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00030-12 · Cited by 89
Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women of eastern Sudan
Adam, I., Khamis, A. H., & Elbashir, M. I. (2005) · Malaria Journal · doi:10.1186/1475-2875-4-18 · Cited by 89
Controlled Human Malaria Infection
Spring, M., Polhemus, M., & Ockenhouse, C. F. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu063 · Cited by 87
Review of the malaria epidemiology and trends in Zambia
Masaninga, F., Chanda, E., Chanda‐Kapata, P., Hamainza, B., Masendu, H., Kamuliwo, M., Kapelwa, W., Chimumbwa, J. M., Govere, J. M., Otten, M. W., et al. (2013) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(13)60030-1 · Cited by 84
Bessoff, K. E., Spangenberg, T., Foderaro, J. E., Jumani, R. S., Ward, G. E., & Huston, C. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02641-13 · Cited by 83
Hansen, F. K., Sumanadasa, S. D. M., Stenzel, K., Duffy, S., Meister, S., Marek, L., Schmetter, R., Kuna, K., Hamacher, A., Mordmüller, B. G., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.050 · Cited by 82
Bethell, D., Se, Y., Lon, C., Tyner, S. D., Saunders, D., Sriwichai, S., Sea, D., Teja‐Isavadharm, P., Khemawoot, P., Schaecher, K. E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019283 · Cited by 79
White, T., Bushdid, P., Ritter, S. H., Laffan, S. B., & Clark, R. (2006) · Birth defects research. Part B. Developmental and reproductice toxicology · doi:10.1002/bdrb.20092 · Cited by 77
Experimentally induced blood stage malaria infection as a tool for clinical research
Engwerda, C. R., Minigo, G., Amante, F. H., & McCarthy, J. S. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.09.001 · Cited by 77
Boyom, F. F., Fokou, P. V. T., Tchokouaha, L. R. Y., Spangenberg, T., Mfopa, A. N., Toghueo, R. M. K., Mbouna, C. D. J., Donfack, V. F. D., & Zollo, P. H. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02541-14 · Cited by 74
Lysine Acetylation in Sexual Stage Malaria Parasites Is a Target for Antimalarial Small Molecules
Trenholme, K. R., Marek, L., Duffy, S., Pradel, G., Fisher, G. M., Hansen, F. K., Skinner‐Adams, T. S., Butterworth, A., Ngwa, C. J., Moecking, J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02721-13 · Cited by 72
Coulibaly, B., Pritsch, M., Bountogo, M., Meissner, P. E., Nebie, E. I., Klose, C., Kieser, M., Berens‐Riha, N., Wieser, A., Sirima, S. B., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu540 · Cited by 69
Mombo‐Ngoma, G., Supan, C., Dal-Bianco, M. P., Missinou, M. A., Matsiegui, P., Salazar, C. L. O., Issifou, S., Ter-Minassian, D., Ramharter, M., Kombila, M., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-53 · Cited by 68
Antigenic Variation in Trypanosoma brucei: Joining the DOTs
Stockdale, C., Swiderski, M. R., Barry, J. D., & McCulloch, R. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060185 · Cited by 67
Gileadi, O., Knapp, S., Lee, W. H., Marsden, B. D., Müller, S., Niesen, F., Kavanagh, K. L., Ball, L., von Delft, F., Doyle, D., et al. (2007) · Journal of Structural and Functional Genomics · doi:10.1007/s10969-007-9027-2 · Cited by 64
Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum
Avery, V. M., Bashyam, S., Burrows, J. N., Duffy, S., Papadatos, G., Puthukkuti, S., Sambandan, Y., Singh, S. V., Spangenberg, T., Waterson, D., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-190 · Cited by 62
Bueno, J. M., Herreros, E., Angulo-Barturen, I., Ferrer, S., Fiandor, J., Gamo, F., Gargallo-Viola, D., & Derimanov, G. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.177 · Cited by 59
Rhinovirus Genome Evolution during Experimental Human Infection
Cordey, S., Junier, T., Gerlach, D., Gobbini, F., Farinelli, L., Zdobnov, E. M., Winther, B., Tapparel, C., & Kaiser, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010588 · Cited by 57
Psychiatric side effects of mefloquine: applications to forensic psychiatry.
Ritchie, E. C., Block, J. J., & Nevin, R. L. (2013) · PubMed · Cited by 54
McAllister, M. Μ. (2014) · Parasitology · doi:10.1017/s0031182013002060 · Cited by 51
The Antimalarial Trioxaquine DU1301 Alkylates Heme in Malaria-Infected Mice
Garah, F. E., Claparols, C., Benoit‐Vical, F., Meunier, B., & Robert, A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-08 · Cited by 43
Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold
Ciana, C., Siegrist, R., Aissaoui, H., Marx, L., Racine, S., Meyer, S., Binkert, C., de Kanter, R., Fischli, C., Wittlin, S., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.118 · Cited by 42
Lanaspa, M., Moraleda, C., Machevo, S., González, R., Serrano, B., Macete, E., Cisteró, P., Mayor, A. G., Hutchinson, D., Kremsner, P. G., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00018-12 · Cited by 39
Is the Tide Turning for New Malaria Medicines?
Wells, T. N. C. (2010) · Science · doi:10.1126/science.1194923 · Cited by 39
Self-citationExperimental human influenza: observations from studies of influenza antivirals
Hayden, F. G. (2012) · Antiviral Therapy · doi:10.3851/imp2062 · Cited by 33
MK-4815, a Potential New Oral Agent for Treatment of Malaria
Powles, M. A., Allocco, J., Yeung, L., Nare, B., Liberator, P., & Schmatz, D. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05326-11 · Cited by 30
Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics
Ghidelli, S., Lafuente-Monasterio, M. J., Waterson, D., Witty, M. J., Younis, Y., Paquet, T., Street, L. J., Chibale, K., Gamo‐Benito, F. J., Bantscheff, M., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-s1-p38 · Cited by 26
MMV in partnership: the Eurartesim® experience
Ubben, D., & Poll, E. M. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-211 · Cited by 25
Shafiq, N., Rajagopalan, S., Kushwaha, H. N., Mittal, N., Chandurkar, N., Bhalla, A., Kaur, S., Pandhi, P., Puri, G. D., Achuthan, S., et al. (2014) · Malaria Research and Treatment · doi:10.1155/2014/372521 · Cited by 24
Tansley, R., Lotharius, J., Priestley, A., Bull, F. A., Duparc, S., & Möhrle, J. J. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.10-0228 · Cited by 21
Malaria and the Millennium Development Goals
Owens, S. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-305441 · Cited by 21
Wijesinghe, R., Occhipinti, J., Bobogare, A., Wini, L., & Whittaker, M. A. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-3 · Cited by 20
Copple, I. M., Chadwick, A. E., Firman, J. W., Donegan, G., Herpers, B., Wong, M. H. L., Chadwick, J., Bringela, A. D., Cristiano, M. L. S., van de Water, B., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00154 · Cited by 19
Lakshminarayana, S. B., Freymond, C., Fischli, C., Yu, J., Weber, S., Goh, A., Yeung, B. K. S., Ho, P. C., Dartois, V. A., Diagana, T. T., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03274-14 · Cited by 17
Single low-dose primaquine to reduce malaria transmission
Steketee, R. W., & ter Kuile, F. O. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70288-3 · Cited by 11
Dwivedi, A., Pal, M. K., Tripathi, A. K., Yadav, N., Mujtaba, S. F., Pant, M. C., Singh, S. K., Mishra, D. P., Ray, R. S., & Prabhu, B. H. M. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.06.210 · Cited by 10
Thelingwani, R., Bonn, B., Chibale, K., & Masimirembwa, C. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.954547 · Cited by 5
Cited by
Phillips, M. A., Burrows, J. N., Manyando, C., van Huijsduijnen, R. H., Van Voorhis, W. C., & Wells, T. N. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.50 · Cited by 649
Self-citationHit and lead criteria in drug discovery for infectious diseases of the developing world
Katsuno, K., Burrows, J. N., Duncan, K., van Huijsduijnen, R. H., Kaneko, T., Kita, K., Mowbray, C. E., Schmatz, D., Warner, P., & Slingsby, B. T. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4683 · Cited by 607
Self-citationAshley, E. A., Pyae Phyo, A., & Woodrow, C. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30324-6 · Cited by 553
New developments in anti-malarial target candidate and product profiles
Burrows, J. N., Duparc, S., Gutteridge, W. E., Hooft van Huijsduijnen, R., Kaszubska, W., Macintyre, F., Mazzuri, S., Möhrle, J. J., & Wells, T. N. C. (2017) · Malaria Journal · doi:10.1186/s12936-016-1675-x · Cited by 520
Self-citationAntimalarial Drug Resistance: A Threat to Malaria Elimination
Menard, D., & Dondorp, A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025619 · Cited by 499
Metadata
- Authors
- Wells, T. N. C., van Huijsduijnen, R. H., & Van Voorhis, W. C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-05-22
- Volume
- 14
- Issue
- 6
- Pages
- 424-442
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1771852563
- Cited by
- 430
- References
- 125
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.